Tsunehiro Oyama Selected Research

Protein-Tyrosine Kinases (Tyrosine Kinase)

1/2009	Association between estrogen receptor-beta expression and epidermal growth factor receptor mutation in the postoperative prognosis of adenocarcinoma of the lung.
1/2006	Epidermal growth factor receptor mutations are associated with gefitinib sensitivity in non-small cell lung cancer in Japanese.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tsunehiro Oyama Research Topics

Disease

33	Neoplasms (Cancer) 04/2021 - 01/2002
17	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2002
16	Lung Neoplasms (Lung Cancer) 04/2021 - 12/2002
6	Esophageal Squamous Cell Carcinoma 09/2015 - 07/2007
6	Neoplasm Metastasis (Metastasis) 05/2011 - 06/2002
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2010 - 09/2005
5	Adenocarcinoma of Lung 04/2011 - 07/2007
4	Esophageal Neoplasms (Esophageal Cancer) 05/2012 - 09/2005
4	Adenocarcinoma 01/2009 - 09/2005
3	Neoplasm Micrometastasis 12/2010 - 01/2002
3	Carcinoma (Carcinomatosis) 05/2006 - 04/2003
2	Carcinogenesis 12/2010 - 05/2006
2	Lymphatic Metastasis 08/2009 - 05/2009
2	Liver Diseases (Liver Disease) 01/2009 - 09/2007
2	Body Weight (Weight, Body) 12/2007 - 02/2007
1	Urinary Bladder Neoplasms (Bladder Cancer) 04/2016
1	Metabolic Bone Diseases (Osteopenia) 05/2011
1	Colonic Neoplasms (Colon Cancer) 04/2011
1	Weight Loss (Weight Reduction) 11/2009
1	Hepatitis 01/2009
1	Ductal Carcinoma 01/2007
1	Scirrhous Adenocarcinoma (Scirrhous Carcinoma) 01/2007
1	Hemorrhage 01/2007
1	Large Cell Carcinoma 09/2005
1	Breast Neoplasms (Breast Cancer) 05/2005

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 05/2011 - 01/2002
8	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2012 - 03/2003
7	Ethanol (Ethyl Alcohol)IBA 09/2015 - 01/2005
7	ErbB Receptors (EGF Receptor)IBA 05/2010 - 01/2006
6	ParaffinIBA 12/2010 - 10/2004
5	AcetaldehydeIBA 09/2015 - 01/2007
4	CarcinogensIBA 09/2015 - 03/2003
4	Aldehyde DehydrogenaseIBA 01/2014 - 09/2005
4	Estrogens (Estrogen)FDA Link 01/2012 - 07/2007
4	Biological ProductsIBA 08/2009 - 03/2005
4	Gefitinib (Iressa)FDA Link 06/2009 - 01/2006
4	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 12/2007 - 12/2002
3	Aromatase (CYP19)IBA 01/2012 - 05/2008
3	Messenger RNA (mRNA)IBA 04/2011 - 12/2007
3	DNA AdductsIBA 12/2010 - 05/2007
3	EnzymesIBA 05/2008 - 02/2002
3	CytochromesIBA 05/2007 - 12/2002
2	Biomarkers (Surrogate Marker)IBA 01/2010 - 01/2009
2	Indicators and Reagents (Reagents)IBA 05/2009 - 10/2005
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2009 - 01/2006
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 05/2007 - 01/2007
2	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 01/2007 - 03/2003
2	Cytochrome P-450 CYP3AIBA 01/2007 - 05/2005
2	Histidine (L-Histidine)FDA Link 05/2006 - 05/2006
2	Tumor Biomarkers (Tumor Markers)IBA 03/2005 - 01/2003
2	Keratins (Keratin)IBA 07/2002 - 01/2002
1	AldehydesIBA 01/2022
1	A 17 (A-17)IBA 04/2021
1	naftopidilIBA 04/2016
1	alpha-1 Adrenergic Receptors (alpha 1 Adrenergic Receptor)IBA 04/2016
1	Anticarcinogenic AgentsIBA 01/2012
1	Lactic Acid (Lactate)FDA LinkGeneric 05/2011
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 04/2011
1	Fluorouracil (Carac)FDA LinkGeneric 01/2011
1	Thymidylate SynthaseIBA 01/2011
1	Vascular Endothelial Growth Factor CIBA 12/2010
1	Cadherins (E-Cadherin)IBA 12/2010
1	gamma Catenin (Plakoglobin)IBA 12/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2010
1	alpha Catenin (alpha E-Catenin)IBA 12/2010
1	beta CateninIBA 12/2010
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 05/2010
1	DeoxyguanosineIBA 01/2010
1	CateninsIBA 05/2009
1	Estrogen ReceptorsIBA 01/2009
1	Estrogen Receptor betaIBA 01/2009
1	Hormones (Hormone)IBA 01/2009
1	Alanine Transaminase (SGPT)IBA 01/2009
1	Aromatase InhibitorsIBA 01/2009
1	SolventsIBA 01/2009
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2009
1	AndrogensIBA 01/2009
1	Vitamin D3 24-HydroxylaseIBA 05/2008
1	Estrogen Receptor alphaIBA 07/2007
1	Gonadal Steroid Hormones (Sex Hormones)IBA 07/2007
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2007
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 07/2007
1	Pharmaceutical PreparationsIBA 01/2007
1	ProdrugsIBA 01/2007
1	Tyrosine Kinase InhibitorsIBA 12/2006
1	Methionine (L-Methionine)FDA Link 12/2006
1	Threonine (L-Threonine)FDA Link 12/2006
1	Cyclin-Dependent Kinase Inhibitor p16IBA 05/2006
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 03/2006
1	Protein Kinases (Protein Kinase)IBA 01/2006
1	involucrinIBA 01/2006
1	Adenosine Triphosphate (ATP)IBA 01/2006
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2006
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 09/2005
1	Endoplasmic Reticulum Chaperone BiPIBA 07/2005
1	Tamoxifen FDA LinkGeneric 05/2005
1	Carcinoembryonic AntigenIBA 03/2005

Therapy/Procedure

4	Therapeutics 01/2012 - 06/2002
1	Oral Administration 04/2016
1	Chemoradiotherapy 01/2011